BCL2 and adult T-cell leukemia/lymphoma: Mechanistically, targeting PP2A downregulated anti-apoptotic BCL-2 family proteins and activated pro-apoptotic cascades, thus overcoming the apoptosis resistance seen in ATLL cells [73].